Log in to save to my catalogue

Citalopram and the KCNE1 D85N variant: a case report on the implications of a genetic modifier

Citalopram and the KCNE1 D85N variant: a case report on the implications of a genetic modifier

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6426086

Citalopram and the KCNE1 D85N variant: a case report on the implications of a genetic modifier

About this item

Full title

Citalopram and the KCNE1 D85N variant: a case report on the implications of a genetic modifier

Publisher

England: Oxford University Press

Journal title

European heart journal : case reports, 2018-12, Vol.2 (4), p.yty106

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Prolongation of the QT interval on the electrocardiogram is clinically important due to the association with an increased risk of sudden cardiac death. A long QT interval may be genetically determined (congenital long QT syndrome) or be drug-induced long QT syndrome e.g. caused by pharmaceutical drugs and electrolyte imbalances.
In this report,...

Alternative Titles

Full title

Citalopram and the KCNE1 D85N variant: a case report on the implications of a genetic modifier

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6426086

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6426086

Other Identifiers

ISSN

2514-2119

E-ISSN

2514-2119

DOI

10.1093/ehjcr/yty106

How to access this item